Amgen, Inc. (AMGN): The Ultimate Biotech Diversification Strategy
You want to invest in biotech. You hear about all the monstrous pops and mini-fortunes that are built overnight.
Amyris Inc. (AMRS)
Market is closed
News
- First
- << Previous
- 31 - 40
Amyris Inc (AMRS): Suing This Synthetic Biology Pioneer Is Silly
Shares of synthetic biology pioneer Amyris Inc (NASDAQ:AMRS) closed Tuesday down 5% and opened today down as much as 8% on news that an investor was bringing a lawsuit against the company with Milberg...
FutureFuel Corp. (FF), Amyris Inc (AMRS): Has Solazyme Inc (SZYM) Become the Perfect Stock?
One thing's for sure: You'll never discover truly great investments unless you actively look for them.
Solazyme Inc (SZYM), Amyris Inc (AMRS): Can These Companies Prove Big Oil Wrong?
Despite being a year of steady progress, 2012 showed the world that industrial biotechnology is still not quite ready for the limelight.
Microsoft Corporation (MSFT), Intel Corporation (INTC), GlaxoSmithKline plc (ADR) (GSK): 8 Projects Bringing Synthetic Biology to Your Doorstep
Bacteria have been Public Enemy No. 1 for most of our species' time on Earth. Although Sir Alexander Fleming discovered penicillin in 1928, it wasn't successfully mass-produced until World War II.
Solazyme Inc (SZYM) Is Planting Itself for Success
Watching a small-cap company come into its own is like watching a plant grow. As investors, we provide the nutrients to help it grow, hoping that the seed of an idea takes root.
Amyris Inc (AMRS) Earnings Show Much Work Remains
Investors looking for signs of life from Amyris Inc (NASDAQ:AMRS) may be pleased with the progress witnessed in the company's fourth-quarter and 2012 full-year earnings released yesterday, but there ...
What Does Solazyme Inc (SZYM)'s 500,000-Liter Fermenter Really Mean?
At the end of 2012, renewable-oils manufacturer Solazyme Inc (NASDAQ:SZYM) announced that it had performed two upstream process runs in 500,000-liter fermenters.
Solazyme Inc (SZYM) Earnings: An Early Look
Earnings season is in full swing, with huge numbers of companies having already given their latest numbers to investors, and Solazyme Inc (NASDAQ:SZYM) is about to release its quarterly earnings report...
3 Reasons to Buy Solazyme Inc (SZYM)
When you go out to a restaurant, would you rather read through a menu with limited options or one with exponential potential to send you into a food coma? Perhaps you have more self-control than I do, ...
- First
- << Previous
- 31 - 40
Billionaire Hedge Funds
